{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:40:07Z","timestamp":1741448407200,"version":"3.38.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2001,11,29]],"date-time":"2001-11-29T00:00:00Z","timestamp":1006992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,29]],"date-time":"2001-11-29T00:00:00Z","timestamp":1006992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1038\/sj.leu.2402291","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T06:31:08Z","timestamp":1313130668000},"page":"1852-1859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes"],"prefix":"10.1038","volume":"15","author":[{"given":"DJ","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MC","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JB","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KL","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JL","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OM","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Silber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,11,29]]},"reference":[{"key":"BF2402291_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00062752-199907000-00010","volume":"6","author":"WG Wierda","year":"1999","unstructured":"Wierda WG, Kipps TJ . Chronic lymphocytic leukemia Curr Opin Hematol 1999 6: 253\u2013261","journal-title":"Curr Opin Hematol"},{"key":"BF2402291_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V88.2.552.bloodjournal882552","volume":"88","author":"KR Rai","year":"1996","unstructured":"Rai KR, Peterson B, Elias L, Shepherd L, Hines J, Nelson D, Cheson B, Kolitz J, Schiffer CA . A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG\/NCI-C and ECOG inter-group study Blood 1996 88: 552\u2013552","journal-title":"Blood"},{"key":"BF2402291_CR3","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2107::AID-CNCR7>3.0.CO;2-L","volume":"79","author":"B Jaksic","year":"1997","unstructured":"Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, Kusec R, Morabito F, Iacopino P, Lutz D . High dose chlorambucil vs Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna Cancer 1997 79: 2107\u20132114","journal-title":"Cancer"},{"key":"BF2402291_CR4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","volume":"347","author":"S Johnson","year":"1996","unstructured":"Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W . Multicentre prospective randomised trial of fludarabine versus vs cyclophosphamide, doxorubicin, and prednisone (CAP) for advanced-stage chronic lymphocytic leukaemia. The French Group on CLL Lancet 1996 347: 1432\u20131438","journal-title":"Lancet"},{"key":"BF2402291_CR5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1200\/JCO.1997.15.4.1567","volume":"15","author":"A Osterborg","year":"1997","unstructured":"Osterborg A, Dyer MJ, Bunjes D, Pangalis GA, Bastion Y, Catovsky D, Mellstedt H . Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia J Clin Oncol 1997 15: 1567\u20131574","journal-title":"J Clin Oncol"},{"key":"BF2402291_CR6","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1182\/blood.V89.11.4146","volume":"89","author":"J Jurlander","year":"1997","unstructured":"Jurlander J, Lai CF, Tan J, Chou CC, Geisler CH, Schriber J, Blumenson LE, Narula SK, Baumann H, Caligiuri MA . Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells Blood 1997 89: 4146\u20134152","journal-title":"Blood"},{"key":"BF2402291_CR7","doi-asserted-by":"crossref","first-page":"31437","DOI":"10.1074\/jbc.273.47.31437","volume":"273","author":"YM Kim","year":"1998","unstructured":"Kim YM, Kim TH, Seol DW, Talanian RV, Billiar TR . Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release J Biol Chem 1998 273: 31437\u201331441","journal-title":"J Biol Chem"},{"key":"BF2402291_CR8","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1172\/JCI117869","volume":"95","author":"AM Genaro","year":"1995","unstructured":"Genaro AM, Hortelano S, Alvarez A, Martineza C, Bosca L . Splenic B-lymphocyte programmed cell-death is prevented by nitric-oxide release through mechanisms involving sustained Bcl-2 levels J Clin Invest 1995 95: 1884\u20131890","journal-title":"J Clin Invest"},{"key":"BF2402291_CR9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V92.3.1031","volume":"92","author":"H Zhao","year":"1998","unstructured":"Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb JP . B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 1998 92: 1031\u20131043","journal-title":"Blood"},{"key":"BF2402291_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.284.5414.651","volume":"284","author":"JB Mannick","year":"1999","unstructured":"Mannick JB, Hausladen A, Liu LM, Hess DT, Zeng M, Miao QX, Kane LS, Gow AJ, Stamler JS . Fas-induced caspase denitrosylation Science 1999 284: 651\u2013654","journal-title":"Science"},{"key":"BF2402291_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/bbrc.1997.7672","volume":"240","author":"J Li","year":"1997","unstructured":"Li J, Billiar TR, Talanian RV, Kim YM . Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation Biochem Biophys Res Commun 1997 240: 419\u2013424","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2402291_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/bbrc.1997.7304","volume":"238","author":"S Mohr","year":"1997","unstructured":"Mohr S, Zech B, Lapetina EG, Brune B . Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide Biochem Biophys Res Commun 1997 238: 387\u2013391","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2402291_CR13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/sj.leu.2401131","volume":"12","author":"PJ Shami","year":"1998","unstructured":"Shami PJ, Sauls DL, Weinberg JB . Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide Leukemia 1998 12: 1461\u20131466","journal-title":"Leukemia"},{"key":"BF2402291_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T Chou","year":"1984","unstructured":"Chou T, Talalay P . Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 1984 22: 27\u201355","journal-title":"Adv Enzyme Regul"},{"key":"BF2402291_CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<311::AID-IJC1>3.0.CO;2-0","volume":"71","author":"F Kanzawa","year":"1997","unstructured":"Kanzawa F, Nishio K, Fukuoka K, Fukuda M, Kunimoto T, Saijo N . Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3 Int J Cancer 1997 71: 311\u2013319","journal-title":"Int J Cancer"},{"key":"BF2402291_CR16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0145-2126(99)00133-2","volume":"23","author":"DP Cohen","year":"1999","unstructured":"Cohen DP, Adams DJ, Flowers JL, Wall ME, Wani MC, Manikumar G, Colvin OM, Silber R . Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes Leukemia Res 1999 23: 1061\u20131070","journal-title":"Leukemia Res"},{"key":"BF2402291_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","volume":"268","author":"LK Keefer","year":"1996","unstructured":"Keefer LK, Nims RW, Davies KM, Wink DA . \u2018NONOates\u2019 (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms: nitric oxide: Pt a \u2013 Sources and detection of No: No Synthase Meth Enzymol 1996 268: 281\u2013293","journal-title":"Meth Enzymol"},{"key":"BF2402291_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/380221a0","volume":"380","author":"L Jia","year":"1996","unstructured":"Jia L, Bonaventura C, Bonaventura J, Stamler JS . S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control Nature 1996 380: 221\u2013226","journal-title":"Nature"},{"key":"BF2402291_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.81.3.372","volume":"81","author":"DJ Pinsky","year":"1997","unstructured":"Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, Malinski T . Mechanical transduction of nitric oxide synthesis in the beating heart Circul Res 1997 81: 372\u2013379","journal-title":"Circul Res"},{"key":"BF2402291_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(95)91211-8","volume":"346","author":"P Vallance","year":"1995","unstructured":"Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T . Direct measurement of nitric oxide in human beings Lancet 1995 346: 153\u2013154","journal-title":"Lancet"},{"key":"BF2402291_CR21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2401940","volume":"14","author":"PT Daniel","year":"2000","unstructured":"Daniel PT . Dissecting the pathways to death Leukemia 2000 14: 2035\u20132044","journal-title":"Leukemia"},{"key":"BF2402291_CR22","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.leu.2401902","volume":"14","author":"E Solary","year":"2000","unstructured":"Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, Garrido O . Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies Leukemia 2000 14: 1833\u20131849","journal-title":"Leukemia"},{"key":"BF2402291_CR23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.leu.2401845","volume":"14","author":"P Huang","year":"2000","unstructured":"Huang P, Sandoval A, Van Den Neste E, Keating MJ, Plunkett W . Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine Leukemia 2000 14: 1405\u20131413","journal-title":"Leukemia"},{"key":"BF2402291_CR24","first-page":"113","volume-title":"Nucleoside Analogs in Cancer Therapy, vol. 12, Basic and Clinical Oncology","author":"A Hanauske","year":"1997","unstructured":"Hanauske A, Von Hoff D . Clinical development of fludarabine. In: Cheson B, Keating M, Plunkett W (eds) Nucleoside Analogs in Cancer Therapy, vol. 12, Basic and Clinical Oncology Dekker: New York 1997 pp 113\u2013158"},{"key":"BF2402291_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.leu.2401684","volume":"14","author":"Y Kano","year":"2000","unstructured":"Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K . In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis Leukemia 2000 14: 379\u2013388","journal-title":"Leukemia"},{"key":"BF2402291_CR26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.leu.2401892","volume":"14","author":"MA Weiss","year":"2000","unstructured":"Weiss MA, Glenn M, Maslak P, Rahman Z, Noy A, Zelenetz A, Scheinberg DA, Golde DW . Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy Leukemia 2000 14: 1577\u20131582","journal-title":"Leukemia"},{"key":"BF2402291_CR27","first-page":"1","volume-title":"Nucleoside Analogs in Cancer Therapy, vol. 12, Basic and Clinical Oncology","author":"W Plunkett","year":"1997","unstructured":"Plunkett W, Gandhi V . Nucleoside analogs: cellular pharmacology, mechanisms of action, and strategies for combination therapy. In: Cheson B, Keating M, Plunkett W (eds) Nucleoside Analogs in Cancer Therapy, vol. 12, Basic and Clinical Oncology Dekker: New York 1997 pp 1\u201335"},{"key":"BF2402291_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/carcin\/15.3.443","volume":"15","author":"F Laval","year":"1994","unstructured":"Laval F, Wink DA . Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase Carcinogenesis 1994 15: 443\u2013447","journal-title":"Carcinogenesis"},{"key":"BF2402291_CR29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V90.1.270.270_270_278","volume":"90","author":"H Iwasaki","year":"1997","unstructured":"Iwasaki H, Huang P, Keating MJ, Plunkett W . Differential incorporation of ara-C, gemcitabine, and fludarabine replicating and repairing DNA in proliferating human leukemia cells Blood 1997 90: 270\u2013278","journal-title":"Blood"},{"key":"BF2402291_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0026-895X(25)10999-1","volume":"39","author":"P Huang","year":"1991","unstructured":"Huang P, Plunkett W . Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism Molec Pharmacol 1991 39: 449\u2013455","journal-title":"Molec Pharmacol"},{"key":"BF2402291_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.275.1.29","volume":"275","author":"D Genini","year":"2000","unstructured":"Genini D, Budihardjo I, Plunkett W, Wang X, Carrera CJ, Cottam HB, Carson DA, Leoni LM . Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway J Biol Chem 2000 275: 29\u201334","journal-title":"J Biol Chem"},{"key":"BF2402291_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7445","volume":"5","author":"DA Frank","year":"1999","unstructured":"Frank DA, Mahajan S, Ritz J . Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling Nature Med 1999 5: 444\u2013447","journal-title":"Nature Med"},{"key":"BF2402291_CR33","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI119869","volume":"100","author":"DA Frank","year":"1997","unstructured":"Frank DA, Mahajan S, Ritz J . B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues J Clin Invest 1997 100: 3140\u20133148","journal-title":"J Clin Invest"},{"key":"BF2402291_CR34","first-page":"1781","volume":"92","author":"MC Levesque","year":"1998","unstructured":"Levesque MC, Adams DJ, Misukonis MA, Flowers J, Silber R, Weinberg JB . Detection of inducible nitric oxide synthase (NOS2) mRNA, antigen and enzyme activity in leukemia cells from patients with CLL Blood 1998 92: 1781","journal-title":"Blood"},{"key":"BF2402291_CR35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.leu.2401896","volume":"14","author":"JP Kolb","year":"2000","unstructured":"Kolb JP . Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia Leukemia 2000 14: 1685\u20131694","journal-title":"Leukemia"},{"key":"BF2402291_CR36","doi-asserted-by":"crossref","first-page":"24125","DOI":"10.1074\/jbc.272.39.24125","volume":"272","author":"JB Mannick","year":"1997","unstructured":"Mannick JB, Miao XQ, Stamler JS . Nitric oxide inhibits Fas-induced apoptosis J Biol Chem 1997 272: 24125\u201324128","journal-title":"J Biol Chem"},{"key":"BF2402291_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0923-2494(91)90103-P","volume":"142","author":"JJ Hibbs","year":"1991","unstructured":"Hibbs JJ . Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity Res Immunol 1991 142: 565\u2013569","journal-title":"Res Immunol"},{"key":"BF2402291_CR38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(94)90269-0","volume":"78","author":"JS Stamler","year":"1994","unstructured":"Stamler JS . Redox signaling \u2013 nitrosylation and related target interactions of nitric-oxide Cell 1994 78: 931\u2013936","journal-title":"Cell"},{"key":"BF2402291_CR39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0005-2728(99)00021-3","volume":"1411","author":"CE Cooper","year":"1999","unstructured":"Cooper CE . Nitric oxide and iron proteins Biochim Biophys Acta 1999 1411: 290\u2013309","journal-title":"Biochim Biophys Acta"},{"key":"BF2402291_CR40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0005-2728(99)00025-0","volume":"1411","author":"GC Brown","year":"1999","unstructured":"Brown GC . Nitric oxide and mitochondrial respiration Biochim Biophys Acta 1999 1411: 351\u2013369","journal-title":"Biochim Biophys Acta"},{"key":"BF2402291_CR41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0703147","volume":"129","author":"B Beltran","year":"2000","unstructured":"Beltran B, Orsi A, Clementi E, Moncada S . Oxidative stress and S-nitrosylation of proteins in cells Br J Pharmacol 2000 129: 953\u2013960","journal-title":"Br J Pharmacol"},{"key":"BF2402291_CR42","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1074\/jbc.274.14.9427","volume":"274","author":"S Mohr","year":"1999","unstructured":"Mohr S, Hallak H, de Boitte A, Lapetina EG, Brune B . Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase J Biol Chem 1999 274: 9427\u20139430","journal-title":"J Biol Chem"},{"key":"BF2402291_CR43","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/carcin\/17.11.2501","volume":"17","author":"M Graziewicz","year":"1996","unstructured":"Graziewicz M, Wink DA, Laval F . Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage Carcinogenesis 1996 17: 2501\u20132505","journal-title":"Carcinogenesis"},{"key":"BF2402291_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/niox.1996.0108","volume":"1","author":"DA Wink","year":"1997","unstructured":"Wink DA, Cook JA, Christodoulou D, Krishna MC, Pacelli R, Kim S, DeGraff W, Gamson J, Vodovotz Y, Russo A, Mitchell JB . Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin Nitric Oxide-Biol Chem 1997 1: 88\u201394","journal-title":"Nitric Oxide-Biol Chem"},{"key":"BF2402291_CR45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/bjc.1997.386","volume":"76","author":"JA Cook","year":"1997","unstructured":"Cook JA, Krishna MC, Pacelli R, DeGraff W, Liebmann J, Mitchell JB, Russo A, Wink DA . Nitric oxide enhancement of melphalan-induced cytotoxicity Br J Cancer 1997 76: 325\u2013334","journal-title":"Br J Cancer"},{"key":"BF2402291_CR46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/jm9903850","volume":"43","author":"JE Saavedra","year":"2000","unstructured":"Saavedra JE, Shami PJ, Wang LY, Davies KM, Booth MN, Citro ML, Keefer LK . Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity J Med Chem 2000 43: 261\u2013269","journal-title":"J Med Chem"},{"key":"BF2402291_CR47","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/jm9701031","volume":"40","author":"JE Saavedra","year":"1997","unstructured":"Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK . Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in liver J Med Chem 1997 40: 1947\u20131954","journal-title":"J Med Chem"},{"key":"BF2402291_CR48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002800050907","volume":"43","author":"F Kanzawa","year":"1999","unstructured":"Kanzawa F, Nishio K, Fukuoka K, Sunami T, Saijo N . In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model Cancer Chemother Pharmacol 1999 43: 353\u2013363","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402291","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:10:17Z","timestamp":1741446617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,29]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["BF2402291"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402291","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2001,11,29]]},"assertion":[{"value":"4 May 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}